Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2347${count})

  • Access to Data and Biospecimens, 2014
    Metabolomic Analysis of Parkinsonian Disorders

    Study Rationale:
    This study is a search for biomarkers of Parkinson’s disease (PD) that would provide early diagnostic clues or a means to monitor disease progression (or both). The analysis involves...

  • Rapid Response Innovation Awards, 2014
    Directed Evolution of Bacteria for Recombinant Expression and Purification of LRRK2

    Study Rationale:                  
    Mutations in the gene that encodes the LRRK2 protein are frequent causes of Parkinson’s disease (PD). An obstacle to understanding how these mutations lead to PD is...

  • Rapid Response Innovation Awards, 2014
    Defining the Contribution of Neuroinflammation to Parkinson's Disease

    Study Rationale:                   
    Over-activation of brain immune cells, called microglia, is associated with the degeneration that occurs in Parkinson’s disease. This suggests that brain...

  • Therapeutic Pipeline Program, 2014
    Augmenting Treatment Effects of Voice Therapy in Parkinson’s Disease

    Study Rationale:                   
    Speech and voice disorders are common in people with Parkinson’s disease (PD) and adversely affect their communication and quality of life. Presently, Lee Silverman...

  • Therapeutic Pipeline Program, 2014
    Prevention of Levodopa-induced Dyskinesia by Transcranial Static Magnetic Field Stimulation

    Study Rationale:
    A major challenge in Parkinson’s treatment is the management of levodopa-induced dyskinesias. A promising approach is offered by non-invasive neuromodulation techniques. We recently...

  • Research Grant, 2014
    Predicting the Efficacious Dose of the Selective 5-HT1A Agonist NLX-112

    Study Rationale:                   
    The dopamine precursor levodopa is the gold-standard treatment for Parkinson’s disease. However, as PD progresses, serotonin neurons increasingly convert levodopa to...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.